Organization Profile

You just read:

OncoGenex Announces Apatorsen Phase 2 Borealis-2 Trial Continues Following Successful Completion of Futility Analysis

News provided by

OncoGenex Pharmaceuticals, Inc.

Dec 09, 2015, 07:00 ET